{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:11:48Z","timestamp":1781788308812,"version":"3.54.5"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Children's Gaucher Research Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The type 1 interferon (IFN) response is part of the innate immune response and best known for its role in viral and bacterial infection. However, this pathway is also induced in sterile inflammation such as that which occurs in a number of neurodegenerative diseases, including neuronopathic Gaucher disease (nGD), a lysosomal storage disorder (LSD) caused by mutations in <jats:italic>GBA<\/jats:italic>.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Mice were injected with conduritol B-epoxide, an irreversible inhibitor of acid beta-glucosidase, the enzyme defective in nGD. MyTrMaSt null mice, where four adaptors of pathogen recognition receptors (PRRs) are deficient, were used to determine the role of the IFN pathway in nGD pathology. Activation of inflammatory and other pathways was analyzed by a variety of methods including RNAseq.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Elevation in the expression of PRRs associated with the IFN response was observed in CBE-injected mice. Ablation of upstream pathways leading to IFN production had no therapeutic benefit on the lifespan of nGD mice but attenuated neuroinflammation. Primary and secondary pathological pathways (i.e., those associated or not with mouse survival) were distinguished, and a set of ~210 genes including those related to sphingolipid, cholesterol, and lipoprotein metabolism, along with a number of inflammatory pathways related to chemokines, TNF, TGF, complement, IL6, and damage-associated microglia were classified as primary pathological pathways, along with some lysosomal and neuronal genes.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Although IFN signaling is the top elevated pathway in nGD, we demonstrate that this pathway is not related to mouse viability and is consequently defined as a secondary pathology pathway. By elimination, we defined a number of critical pathways that are directly related to brain pathology in nGD, which in addition to its usefulness in understanding pathophysiological mechanisms, may also pave the way for the development of novel therapeutic paradigms by targeting such pathways.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12974-020-01934-x","type":"journal-article","created":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T03:15:22Z","timestamp":1599448522000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Mice defective in interferon signaling help distinguish between primary and secondary pathological pathways in a mouse model of neuronal forms of Gaucher disease"],"prefix":"10.1186","volume":"17","author":[{"given":"Ayelet","family":"Vardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifra","family":"Ben-Dor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Min","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Kalinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Spanier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0013-0115","authenticated-orcid":false,"given":"Anthony H.","family":"Futerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,7]]},"reference":[{"key":"1934_CR1","doi-asserted-by":"crossref","unstructured":"Futerman AH, Zimran A. Gaucher disease. Taylor and Francis Group, Boca Raton, FL: CRC Press; 2006.","DOI":"10.1201\/9781420005509"},{"key":"1934_CR2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ymgme.2016.11.006","volume":"120","author":"PK Mistry","year":"2017","unstructured":"Mistry PK, Lopez G, Schiffmann R, Barton NW, Weinreb NJ, Sidransky E. Gaucher disease: progress and ongoing challenges. Mol Genet Metab Academic Press. 2017;120:8\u201321.","journal-title":"Mol Genet Metab Academic Press"},{"key":"1934_CR3","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nm.3449","volume":"20","author":"EB Vitner","year":"2014","unstructured":"Vitner EB, Salomon R, Farfel-Becker T, Meshcheriakova A, Ali M, Klein AD, et al. RIPK3 as a potential therapeutic target for Gaucher\u2019s disease. Nat Med. 2014;20:204\u20138.","journal-title":"Nat Med"},{"key":"1934_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-015-0467-5","volume":"13","author":"EB Vitner","year":"2016","unstructured":"Vitner EB, Farfel-Becker T, Ferreira NS, Leshkowitz D, Sharma P, Lang KS, et al. Induction of the type I interferon response in neurological forms of Gaucher disease. J Neuroinflammation BioMed Central. 2016;13:1\u201315.","journal-title":"J Neuroinflammation BioMed Central"},{"key":"1934_CR5","doi-asserted-by":"crossref","first-page":"17483","DOI":"10.1073\/pnas.0708086104","volume":"104","author":"IB Enquist","year":"2007","unstructured":"Enquist IB, Bianco Lo C, Ooka A, Nilsson E, M\u00e5nsson J-E, Ehinger M, et al. Murine models of acute neuronopathic Gaucher disease. Proc Natl Acad Sci U S A National Acad Sciences. 2007;104:17483\u20138.","journal-title":"Proc Natl Acad Sci U S A National Acad Sciences"},{"key":"1934_CR6","first-page":"35237","volume":"289","author":"L Schaefer","year":"2014","unstructured":"Schaefer L. Complexity of Danger: The diverse nature of damage-associated molecular patterns. J Biol Chem American Society for Biochemistry and Molecular Biology. 2014;289:35237\u201345.","journal-title":"J Biol Chem American Society for Biochemistry and Molecular Biology"},{"key":"1934_CR7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nri2079","volume":"7","author":"LAJ O'Neill","year":"2007","unstructured":"O'Neill LAJ, Bowie AG. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol. 2007;7:353\u201364.","journal-title":"Nat Rev Immunol"},{"key":"1934_CR8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nri3787","volume":"15","author":"F McNab","year":"2015","unstructured":"McNab F, Mayer-Barber K, Sher A, Wack A, O'Garra A. Type I interferons in infectious disease. Nat Rev Immunol Nature Research. 2015;15:87\u2013103.","journal-title":"Nat Rev Immunol Nature Research"},{"key":"1934_CR9","first-page":"380","volume":"498","author":"A Ablasser","year":"2013","unstructured":"Ablasser A, Goldeck M, Cavlar T, Deimling T, Witte G, R\u00f6hl I, et al. cGAS produces a 2\u2032-5\u2032-linked cyclic dinucleotide second messenger that activates STING. Nature Nature Publishing Group. 2013;498:380\u20134.","journal-title":"Nature Nature Publishing Group"},{"key":"1934_CR10","first-page":"496","volume":"239","author":"A Vardi","year":"2016","unstructured":"Vardi A, Zigdon H, Meshcheriakova A, Klein AD, Yaacobi C, Eilam R, et al. Delineating pathological pathways in a chemically induced mouse model of Gaucher disease. J Pathol John Wiley & Sons, Ltd. 2016;239:496\u2013509.","journal-title":"J Pathol John Wiley & Sons, Ltd"},{"key":"1934_CR11","doi-asserted-by":"crossref","unstructured":"Kuo CL, Kallemeijn WW, Lelieveld LT, Mirzaian M, Zoutendijk I, Vardi A, et al. In vivo inactivation of glycosidases by conduritol B epoxide and cyclophellitol as revealed by activity-based protein profiling. The FEBS Journal. John Wiley & Sons, Ltd (10.1111); 2019;286:584\u2013600.","DOI":"10.1111\/febs.14744"},{"key":"1934_CR12","first-page":"1","volume":"10","author":"P-K Tegtmeyer","year":"2019","unstructured":"Tegtmeyer P-K, Spanier J, Borst K, Becker J, Riedl A, Hirche C, et al. STING induces early IFN-\u03b2 in the liver and constrains myeloid cell-mediated dissemination of murine cytomegalovirus. Nat. Commun. Nat Publ Group. 2019;10:1\u201312.","journal-title":"Nat Publ Group"},{"key":"1934_CR13","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real time quantitative PCR and the 2^(-\u0394\u0394C(T)) method. Methods. 2001;25:402\u20138.","journal-title":"Methods."},{"key":"1934_CR14","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1126\/science.1247651","volume":"343","author":"DA Jaitin","year":"2014","unstructured":"Jaitin DA, Kenigsberg E, Keren-Shaul H, Elefant N, Paul F, Zaretsky I, et al. Massively parallel single-cell RNA-Seq for marker-free decomposition of tissues into cell types. Science. American Association for the Advancement of Science. 2014;343:776\u20139.","journal-title":"American Association for the Advancement of Science"},{"key":"1934_CR15","first-page":"1","volume":"20","author":"R Kohen","year":"2019","unstructured":"Kohen R, Barlev J, Hornung G, Stelzer G, Feldmesser E, Kogan K, et al. UTAP: User-friendly transcriptome analysis pipeline. BMC Bioinformatics. BioMed Central. 2019;20:1\u20137.","journal-title":"BioMed Central"},{"key":"1934_CR16","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1186\/1471-2164-9-488","volume":"9","author":"T Hulsen","year":"2008","unstructured":"Hulsen T, Vlieg J, Alkema W. BioVenn - a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. BMC Genomics BioMed Central. 2008;9:488.","journal-title":"BMC Genomics BioMed Central"},{"key":"1934_CR17","first-page":"1","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun Nature Publishing Group. 2019;10:1\u201310.","journal-title":"Nat Commun Nature Publishing Group"},{"key":"1934_CR18","doi-asserted-by":"crossref","unstructured":"Ben-Ari Fuchs S, Lieder I, Stelzer G, Mazor Y, Buzhor E, Kaplan S, et al. GeneAnalytics: an integrative gene set analysis tool for next generation sequencing, RNAseq and microarray data. OMICS. Mary Ann Liebert, Inc. 140 Huguenot Street, 3rd Floor New Rochelle, NY 10801 USA; 2016;20:139\u201351.","DOI":"10.1089\/omi.2015.0168"},{"key":"1934_CR19","first-page":"305","volume":"32","author":"AL Blasius","year":"2010","unstructured":"Blasius AL, Beutler B. Intracellular Toll-like receptors. Immunity Elsevier Inc. 2010;32:305\u201315.","journal-title":"Immunity Elsevier Inc"},{"key":"1934_CR20","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/ni.1782","volume":"10","author":"A Sabbah","year":"2009","unstructured":"Sabbah A, Te HC, Harnack R, Frohlich V, Tominaga K, Dube PH, et al. Activation of innate immune antiviral responses by Nod2. Nat Immunol Nature Publishing Group. 2009;10:1073\u201380.","journal-title":"Nat Immunol Nature Publishing Group"},{"key":"1934_CR21","first-page":"674","volume":"455","author":"H Ishikawa","year":"2008","unstructured":"Ishikawa H, Barber GN. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature Nature Publishing Group. 2008;455:674\u20138.","journal-title":"Nature Nature Publishing Group"},{"key":"1934_CR22","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/brain\/aws095","volume":"135","author":"EB Vitner","year":"2012","unstructured":"Vitner EB, Farfel-Becker T, Eilam R, Biton I, Futerman AH, Futerman A. Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher\u2019s disease. Brain. 2012;135:1724\u201335.","journal-title":"Brain."},{"key":"1934_CR23","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1016\/j.celrep.2016.07.085","volume":"16","author":"AD Klein","year":"2016","unstructured":"Klein AD, Ferreira NS, Ben-Dor S, Duan J, Hardy J, Cox TM, et al. Identification of modifier genes in a mouse model of Gaucher disease. Cell Rep Cell Press. 2016;16:2546\u201353.","journal-title":"Cell Rep Cell Press"},{"key":"1934_CR24","doi-asserted-by":"crossref","unstructured":"Franz\u00e9n O, Gan LM, Bj\u00f6rkegren J. PanglaoDB: a web server for exploration of mouse and human single-cell RNA sequencing data. Database. 2019.","DOI":"10.1093\/database\/baz046"},{"key":"1934_CR25","first-page":"566","volume":"167","author":"G La Manno","year":"2016","unstructured":"La Manno G, Gyllborg D, Codeluppi S, Nishimura K, Salto C, Zeisel A, et al. Molecular diversity of midbrain development in mouse, human, and stem cells. Cell Cell Press. 2016;167:566\u2013580.e19.","journal-title":"Cell Cell Press"},{"key":"1934_CR26","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/1873-3468.12591","volume":"591","author":"H Zigdon","year":"2017","unstructured":"Zigdon H, Meshcheriakova A, Becker TF, Volpert G, Sabanay H, Futerman AH. Altered lysosome distribution is an early neuropathological event in neurological forms of Gaucher disease. FEBS Lett John Wiley & Sons, Ltd. 2017;591:774\u201383.","journal-title":"FEBS Lett John Wiley & Sons, Ltd"},{"key":"1934_CR27","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/hmg\/ddr019","volume":"20","author":"T Farfel-Becker","year":"2011","unstructured":"Farfel-Becker T, Vitner EB, Pressey SNR, Eilam R, Cooper JD, Futerman AH. Spatial and temporal correlation between neuron loss and neuroinflammation in a mouse model of neuronopathic Gaucher disease. Hum Mol Genet Oxford University Press. 2011;20:1375\u201386.","journal-title":"Hum Mol Genet Oxford University Press"},{"key":"1934_CR28","first-page":"R628","volume":"26","author":"A Yaron","year":"2016","unstructured":"Yaron A, Schuldiner O. Common and divergent mechanisms in developmental neuronal remodeling and dying back neurodegeneration. Current Biology Cell Press. 2016;26:R628\u201339.","journal-title":"Current Biology Cell Press"},{"key":"1934_CR29","first-page":"1257","volume":"12","author":"X Han","year":"2018","unstructured":"Han X, Zhu J, Zhang X, Song Q, Ding J, Lu M, et al. Plin4-dependent lipid droplets hamper neuronal mitophagy in the MPTP\/p-induced mouse model of Parkinson\u2019s disease. Front Neurosci Frontiers. 2018;12:1257.","journal-title":"Front Neurosci Frontiers"},{"key":"1934_CR30","doi-asserted-by":"crossref","first-page":"7964","DOI":"10.1523\/JNEUROSCI.20-21-07964.2000","volume":"20","author":"U Schlomann","year":"2000","unstructured":"Schlomann U, Rathke-Hartlieb S, Yamamoto S, Jockusch H, Bartsch JW. Tumor necrosis factor \u03b1 induces a metalloprotease-disintegrin, ADAM8 (CD 156): implications for neuron\u2013glia interactions during neurodegeneration. J Neurosci Society for Neuroscience. 2000;20:7964\u201371.","journal-title":"J Neurosci Society for Neuroscience"},{"key":"1934_CR31","first-page":"133","volume":"20","author":"THJ Yoon-Seong Kim","year":"2012","unstructured":"Yoon-Seong Kim THJ. Matrix metalloproteinases, new insights into the understanding of neurodegenerative disorders. Biomol Ther Korean Society of Applied Pharmacology. 2012;20:133\u201343.","journal-title":"Biomol Ther Korean Society of Applied Pharmacology"},{"key":"1934_CR32","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/hmg\/ddy182","volume":"27","author":"LD Weinstock","year":"2018","unstructured":"Weinstock LD, Furness AM, Herron SS, Smith SS, Sankar SB, DeRosa SG, et al. Fingolimod phosphate inhibits astrocyte inflammatory activity in mucolipidosis IV. Hum Mol Genet. 2018;27:2725\u201338.","journal-title":"Hum Mol Genet"},{"key":"1934_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-018-1391-2","volume":"16","author":"A Cougnoux","year":"2019","unstructured":"Cougnoux A, Drummond RA, Fellmeth M, Navid F, Collar AL, Iben J, et al. Unique molecular signature in mucolipidosis type IV microglia. J Neuroinflammation BioMed Central. 2019;16:1\u201312.","journal-title":"J Neuroinflammation BioMed Central"},{"key":"1934_CR34","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrneurol.2015.143","volume":"11","author":"S McGlasson","year":"2015","unstructured":"McGlasson S, Jury A, Jackson A, Hunt D. Type I interferon dysregulation and neurological disease. Nat Rev Neurol Nature Publishing Group. 2015;11:515\u201323.","journal-title":"Nat Rev Neurol Nature Publishing Group"},{"key":"1934_CR35","first-page":"27384","volume":"284","author":"SW Wong","year":"2009","unstructured":"Wong SW, Kwon M-J, Choi AMK, Kim H-P, Nakahira K, Hwang DH. Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J Biol Chem American Society for Biochemistry and Molecular Biology. 2009;284:27384\u201392.","journal-title":"J Biol Chem American Society for Biochemistry and Molecular Biology"},{"key":"1934_CR36","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.bbamem.2012.11.018","volume":"1828","author":"ARP Varela","year":"2013","unstructured":"Varela ARP, Gon\u00e7alves da Silva AMPS, Fedorov A, Futerman AH, Prieto M, Silva LC. Effect of glucosylceramide on the biophysical properties of fluid membranes. Biochim Biophys Acta Elsevier. 2013;1828:1122\u201330.","journal-title":"Biochim Biophys Acta Elsevier"},{"key":"1934_CR37","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1517\/14728222.2014.981530","volume":"19","author":"EB Vitner","year":"2014","unstructured":"Vitner EB, Vardi A, Cox TM, Futerman AH. Emerging therapeutic targets for Gaucher disease. Expert Opin Ther Targets Informa UK, Ltd. 2014;19:321\u201334.","journal-title":"Expert Opin Ther Targets Informa UK, Ltd"},{"key":"1934_CR38","first-page":"793","volume":"2016","author":"C-W Wang","year":"1861","unstructured":"Wang C-W. Lipid droplets, lipophagy, and beyond. Biochim Biophys Acta Elsevier. 1861;2016:793\u2013805.","journal-title":"Biochim Biophys Acta Elsevier"},{"key":"1934_CR39","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.molcel.2018.11.028","volume":"73","author":"S Fanning","year":"2019","unstructured":"Fanning S, Haque A, Imberdis T, Baru V, Barrasa MI, Nuber S, et al. Lipidomic analysis of \u03b1-synuclein neurotoxicity identifies stearoyl CoA desaturase as a target for Parkinson treatment. Mol Cell Cell Press. 2019;73:1001\u20138.","journal-title":"Mol Cell Cell Press"},{"key":"1934_CR40","first-page":"454","volume":"722827","author":"J Marschallinger","year":"2019","unstructured":"Marschallinger J, Iram T, Zardeneta M, Lee SE, Lehallier B, Haney MS, et al. Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain. bioRxiv. Cold Spring Harbor Laboratory. 2019;722827:454.","journal-title":"Cold Spring Harbor Laboratory"},{"key":"1934_CR41","first-page":"1276","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell Cell Press. 2017;169:1276\u20131290.e17.","journal-title":"Cell Cell Press"},{"key":"1934_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-017-1027-y","volume":"15","author":"J-T Li","year":"2018","unstructured":"Li J-T, Zhang Y. TREM2 regulates innate immunity in Alzheimer\u2019s disease. J Neuroinflammation BioMed Central. 2018;15:1\u20137.","journal-title":"J Neuroinflammation BioMed Central"},{"key":"1934_CR43","first-page":"1171","volume":"68","author":"S-L Zhou","year":"2019","unstructured":"Zhou S-L, Tan C-C, Hou X-H, Cao X-P, Tan L, Yu J-T. TREM2 variants and neurodegenerative diseases: a systematic review and meta-analysis. Zhu L-Q, editor J Alzheimers Dis IOS Press. 2019;68:1171\u201384.","journal-title":"Zhu L-Q, editor J Alzheimers Dis IOS Press"},{"key":"1934_CR44","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.expneurol.2018.01.016","volume":"302","author":"M Ren","year":"2018","unstructured":"Ren M, Guo Y, Wei X, Yan S, Qin Y, Zhang X, et al. TREM2 overexpression attenuates neuroinflammation and protects dopaminergic neurons in experimental models of Parkinson's disease. Exp Neurol Academic Press. 2018;302:205\u201313.","journal-title":"Exp Neurol Academic Press"},{"key":"1934_CR45","first-page":"512","volume":"23","author":"FL Yeh","year":"2017","unstructured":"Yeh FL, Hansen DV, Sheng M. TREM2, microglia, and neurodegenerative diseases. Trends Mol Med Elsevier Current Trends. 2017;23:512\u201333.","journal-title":"Trends Mol Med Elsevier Current Trends"},{"key":"1934_CR46","doi-asserted-by":"crossref","unstructured":"Cho SM, Vardi A, Platt N, Futerman AH. Absence of infiltrating peripheral myeloid cells in the brains of mouse models of lysosomal storage disorders. Kielian T, editor. J. Neurochem. John Wiley & Sons, Ltd (10.1111); 2019;148:625\u201338.","DOI":"10.1111\/jnc.14483"},{"key":"1934_CR47","first-page":"12","volume":"e1002466","author":"H Konishi","year":"2018","unstructured":"Konishi H, Kiyama H. Microglial TREM2\/DAP12 signaling: a double-edged sword in neural diseases. Front Cell Neurosci Frontiers. 2018;e1002466:12.","journal-title":"Front Cell Neurosci Frontiers"},{"key":"1934_CR48","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev-immunol-032713-120154","volume":"32","author":"VM Holers","year":"2014","unstructured":"Holers VM. Complement and its receptors: new insights into human disease. Annu Rev Immunol Annual Reviews. 2014;32:433\u201359.","journal-title":"Annu Rev Immunol Annual Reviews"},{"key":"1934_CR49","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.smim.2018.02.006","volume":"37","author":"MK Pandey","year":"2018","unstructured":"Pandey MK, Grabowski GA, K\u00f6hl J. An unexpected player in Gaucher disease: the multiple roles of complement in disease development. Semin Immunol Academic Press. 2018;37:30\u201342.","journal-title":"Semin Immunol Academic Press"},{"key":"1934_CR50","first-page":"108","volume":"543","author":"MK Pandey","year":"2017","unstructured":"Pandey MK, Burrow TA, Rani R, Martin LJ, Witte D, Setchell KD, et al. Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease. Nature Nature Publishing Group. 2017;543:108\u201312.","journal-title":"Nature Nature Publishing Group"},{"key":"1934_CR51","doi-asserted-by":"crossref","unstructured":"Wang X-X, Tan M-S, Yu J-T, Tan L. Matrix metalloproteinases and their multiple roles in Alzheimer\u2019s disease. Biomed Res Int. Hindawi; 2014;2014:1\u20138.","DOI":"10.1155\/2014\/908636"},{"key":"1934_CR52","first-page":"1","volume":"96","author":"PH Reddy","year":"2006","unstructured":"Reddy PH. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer\u2019s disease. J. Neurochem. John Wiley & Sons. Ltd. 2006;96:1\u201313.","journal-title":"Ltd"},{"key":"1934_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/5828056","volume":"2017","author":"D Ju\u00e1rez-Rebollar","year":"2017","unstructured":"Ju\u00e1rez-Rebollar D, Rios C, Nava-Ru\u00edz C, M\u00e9ndez-Armenta M. Metallothionein in brain disorders. Oxid Med Cell Longev Hindawi. 2017;2017:1\u201312.","journal-title":"Oxid Med Cell Longev Hindawi"},{"key":"1934_CR54","doi-asserted-by":"crossref","unstructured":"Costa R, Ferreira-da-Silva F, Saraiva MJ. (null) IC. Transthyretin protects against A-beta peptide toxicity by proteolytic cleavage of the peptide: a mechanism sensitive to the Kunitz protease inhibitor. PLoS One. 2008;3.","DOI":"10.1371\/journal.pone.0002899"},{"key":"1934_CR55","first-page":"126","volume":"64","author":"CRA Santos","year":"2012","unstructured":"Santos CRA, Martinho A, Quintela T, Gon\u00e7alves I. Neuroprotective and neuroregenerative properties of metallothioneins. IUBMB Life. John Wiley & Sons. Ltd. 2012;64:126\u201335.","journal-title":"Ltd"},{"key":"1934_CR56","first-page":"5003","volume":"581","author":"I Miyazaki","year":"2007","unstructured":"Miyazaki I, Asanuma M, Hozumi H, Miyoshi K, Sogawa N. Protective effects of metallothionein against dopamine quinone-induced dopaminergic neurotoxicity. FEBS Lett No longer published by Elsevier. 2007;581:5003\u20138.","journal-title":"FEBS Lett No longer published by Elsevier"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-020-01934-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-020-01934-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-020-01934-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T23:33:38Z","timestamp":1630971218000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-020-01934-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,7]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1934"],"URL":"https:\/\/doi.org\/10.1186\/s12974-020-01934-x","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,7]]},"assertion":[{"value":"27 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Mice were maintained under specific pathogen-free conditions and handled according to protocols approved by the Weizmann Institute Animal Care Committee according to international guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"265"}}